Table 2 Prevalence of cardiovascular risk factors (CVRF) by age category and gender in the ORISCAV-LUX study
From: First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX)
CVRF | Â | 18-69 n (%) | 18-29 n (%) | 30-39 n (%) | 40-49 n (%) | 50-59 n (%) | 60-69 n (%) | P-value* | P-value** |
|---|---|---|---|---|---|---|---|---|---|
Obesity | Total | 325 (20.9) | Â | Â | Â | Â | Â | Â | Â |
| Â | Men | 175 (23) | 7 (6.3) | 35 (20.3) | 50 (26.6) | 45 (32.9) | 38 38.6) | <0.0001 | 0.03 |
| Â | Women | 150 (18.7) | 7 (6.7) | 28 14.2) | 40 (20.6) | 32 (22.2) | 43 (39.4) | Â | Â |
Hypertension | Total | 540 (34.5) | Â | Â | Â | Â | Â | Â | Â |
| Â | Men | 322 (41.9) | 10 (9.3) | 50 (28.7) | 95 (50.2) | 86 (63.0) | 81 (84.1) | <0.0001 | <0.0001 |
| Â | Women | 218 (27.1) | 7 (6.3) | 22 (13.1) | 51 (26.7) | 64 (43.5) | 74 (67.8) | Â | Â |
Diabetes | Total | 69 (4.4) | Â | Â | Â | Â | Â | Â | Â |
| Â | Men | 39 (5.2) | 1 (1.1) | 1 (0.7) | 7 (3.8) | 12 (8.8) | 18 (18.8) | <0.0001 | 0.08 |
| Â | Women | 30 (3.5%) | 0 (-) | 1 (0.5) | 5 (2.4) | 8 (5.3) | 16 (14.7) | Â | Â |
Lipid disorder | Total | 1033 (69.9) | Â | Â | Â | Â | Â | Â | Â |
| Â | Men | 533 (74.3) | 44 (42.7) | 119 (70.9) | 159 (84.5) | 120 (89.7) | 91 (96.5) | <0.0001 | 0.0002 |
| Â | Women | 500 (65.5) | 48 (42.3) | 93 (52.0) | 124 (67.8) | 136 (92.0) | 99 (92.0) | Â | Â |
Current smoking | Total | 307 (22.3) | Â | Â | Â | Â | Â | Â | Â |
| Â | Men | 165 (24.9) | 41 (38.6) | 39 (22.7) | 46 (24.5) | 30 (22.4) | 9 (8.6) | <0.0001 | 0.03 |
| Â | Women | 142 (19.7) | 33 (28.7) | 32 (17.3) | 31 (16.7) | 31 (20.3) | 15 (13.0) | Â | Â |
R-ATPIII-defined MS | Total | 368 (24.0) | 9 (4.4) | 40 (11.6) | 95 (25.5) | 114 (42.1) | 110 (55.1) | <0.0001 | <0.0001 |
| Â | Men | 221 (29.5) | 7 (6.9) | 26 (15.6) | 62 (33.8) | 67 (50.5) | 59 (61.2) | Â | Â |
| Â | Women | 147 (18.4) | 2 (2.0) | 14 (7.5) | 33 (17.1) | 47 (33.3) | 51 (49.4) | Â | Â |